如何在动脉狭窄时达到最佳的心血管风险
1Department of Cardiology, Laboratory for Atherosclerosis Research, Institute of Clinical and Experimental Medicine, Prague, Czech Republic - japi@ikem.cz.
概括
控制吸烟,高胆固醇,高血压和糖尿病等可改变的风险因素对于患有动脉狭窄症的患者来说至关重要,
科学领域:
- 心血管医学
- 神经学
- 公共卫生
背景情况:
- 动脉狭窄会导致缺血性中风和其他致命的心血管事件的重大风险.
- 无论症状表现如何,对可改变的心血管风险因素的有效管理至关重要.
研究的目的:
- 概述一个全面的策略来管理患有动脉狭窄的患者的心血管风险因素.
- 强调改变生活方式和药物治疗对于降低中风和心血管事件风险的重要性.
主要方法:
- 实施生活方式 (0-5-30规则:零烟,5份水果/蔬菜,每天运动30分钟).
- 通过药理控制血脂不良,达到非常低的LDL胆固醇水平 (< 1.4 mmol/ L).
- 治疗高血压以达到 130-140 mmHg 的目标血压,在严重的病例中谨慎降低.
主要成果:
- 使用强效的低脂药物可以达到非常低的LDL胆固醇度.
- 最佳的静脉压目标为130-140mmHg,在严重的动脉狭窄时要小心定位.
- 现代抗糖尿病药物提供了更安全的方法,
结论:
- 心血管风险因素的综合管理,包括改变生活方式和药物治疗,对于患有动脉狭窄症的患者至关重要.
- 解决脂肪蛋白 (a),亚临床炎症和患者不依附等因素对于最佳结果至关重要.
- 综合风险因素控制可显著降低该患者中风和心血管死亡的风险.
相关概念视频
Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
Coronary Artery Disease IV: Preventive Measures
32
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
32
Coronary Artery Disease V: Interprofessional Care
30
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
30
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
119
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
119
Peripheral Artery Disease III: Interprofessional Care
29
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
29
Coronary Artery Disease I: Introduction
55
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
55


